{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:13Z","timestamp":1787020153087,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1002-0","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T18:32:41Z","timestamp":1436034761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Shohreh","family":"Honarbakhsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012;3:388.","journal-title":"Front Microbiol"},{"key":"1002_CR2","volume-title":"Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses","author":"IARC Monographs on the Evaluation of Carcinogenic Risk to Humans","year":"1996","unstructured":"IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses. Lyon: IARC; 1996."},{"key":"1002_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/ijc.2910430618","volume":"43","author":"T Kondo","year":"1989","unstructured":"Kondo T, Kono H, Miyamoto N, Yoshida R, Toki H, Matsumoto I, et al. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer. 1989;43:1061\u20134.","journal-title":"Int J Cancer"},{"key":"1002_CR4","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031\u20132.","journal-title":"Lancet"},{"key":"1002_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Vernant JC, Maurs L, Barin F, Gout O, Maurs L, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407\u20139.","journal-title":"Lancet"},{"key":"1002_CR6","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1212\/01.WNL.0000096011.92542.DA","volume":"61","author":"JR Orland","year":"2003","unstructured":"Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C, et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology. 2003;61:1588\u201394.","journal-title":"Neurology"},{"key":"1002_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0002-9394(02)01521-0","volume":"134","author":"H Merle","year":"2002","unstructured":"Merle H, Cabre P, Olindo S, Merle S, Smadja D. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol. 2002;134:190\u20135.","journal-title":"Am J Ophthalmol"},{"key":"1002_CR8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0140-6736(89)91793-5","volume":"2","author":"OS Morgan","year":"1989","unstructured":"Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet. 1989;2:1184\u20137.","journal-title":"Lancet"},{"key":"1002_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0140-6736(89)90038-X","volume":"1","author":"K Nishioka","year":"1989","unstructured":"Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989;1:441.","journal-title":"Lancet"},{"key":"1002_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/ard.56.3.167","volume":"56","author":"H Nakamura","year":"1997","unstructured":"Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A, et al: High prevalence of Sjogren's syndrome in patients with HTLV-1 associated myelopathy. Ann Rheum Dis 1997;56:167\u201372.","journal-title":"Ann Rheum Dis"},{"key":"1002_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/13550289509111010","volume":"1","author":"M Nakagawa","year":"1995","unstructured":"Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol. 1995;1:50\u201361.","journal-title":"J Neurovirol"},{"key":"1002_CR12","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2169\/internalmedicine.31.1213","volume":"31","author":"H Kawai","year":"1992","unstructured":"Kawai H, Saito M, Takagi M, Tsuchihashi T, Arii Y, Kondo A, et al. Hashimoto\u201ds thyroiditis in HTLV-I carriers. Intern Med. 1992;31:1213\u20136.","journal-title":"Intern Med"},{"key":"1002_CR13","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/0140-6736(90)92896-P","volume":"336","author":"L LaGrenade","year":"1990","unstructured":"LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet. 1990;336:1345\u20137.","journal-title":"Lancet"},{"key":"1002_CR14","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/eji.200939451","volume":"39","author":"CR Bangham","year":"2009","unstructured":"Bangham CR. CTL quality and the control of human retroviral infections. Eur J Immunol. 2009;39:1700\u201312.","journal-title":"Eur J Immunol"},{"key":"1002_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, et al. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998;4:586\u201393.","journal-title":"J Neurovirol"},{"key":"1002_CR16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1086\/342953","volume":"186","author":"AM Vine","year":"2002","unstructured":"Vine AM, Witkover A, Lloyd AL, Jeffery K, Siddiqui AA, Marshall SE, et al. Polygenic control of HTLV-I proviral load and the risk of HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). J Infect Dis. 2002;186:932\u20139.","journal-title":"J Infect Dis"},{"key":"1002_CR17","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1210\/jc.2005-0679","volume":"90","author":"T Matsuda","year":"2005","unstructured":"Matsuda T, Tomita M, Uchihara JN, Okudaira T, Ohshiro K, Tomoyose T, et al. Human T cell leukemia virus type I-infected patients with Hashimoto\u2019s thyroiditis and Graves\u2019 disease. J Clin Endocrinol Metab. 2005;90:5704\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"1002_CR18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/aid.2012.0132","volume":"29","author":"MA Demontis","year":"2013","unstructured":"Demontis MA, Hilburn S, Taylor GP. HTLV-1 viral load variability and long-term trends in asymptomatic carriers and in patients with HTLV-1-related diseases. AIDS Res Hum Retroviruses. 2013;29:359\u201364.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1002_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/thx.2004.021667","volume":"60","author":"S Mori","year":"2005","unstructured":"Mori S, Mizoguchi A, Kawabata M, Fukunaga H, Usuku K, Maruyama I, et al. Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers. Thorax. 2005;60:138\u201343.","journal-title":"Thorax"},{"key":"1002_CR20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4269\/ajtmh.1993.48.170","volume":"48","author":"S Mita","year":"1993","unstructured":"Mita S, Sugimoto M, Nakamura M, Murakami T, Tokunaga M, Uyama E, et al. Increased Human T Lymphotropic Virus Type-1 (HTLV-1) Proviral DNA in Peripheral Blood Mononuclear Cells and Bronchoalveolar Lavage Cells from Japanese Patients with HTLV-1-Associated Myelopathy. Am J Trop Med Hyg. 1993;48:170\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"1002_CR21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1183\/09031936.93.06070938","volume":"6","author":"M Sugimoto","year":"1993","unstructured":"Sugimoto M, Mita S, Tokunaga M, Yamaguchi K, Cho I, Matsumoto M, et al. Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid. Eur Respir J. 1993;6:938\u201343.","journal-title":"Eur Respir J"},{"key":"1002_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1148\/radiol.2402050886","volume":"240","author":"F Okada","year":"2006","unstructured":"Okada F, Ando Y, Yoshitake S, Yotsumoto S, Matsumoto S, Wakisaka M, et al. Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology. 2006;240:559\u201364.","journal-title":"Radiology"},{"key":"1002_CR23","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1164\/ajrccm\/139.6.1329","volume":"139","author":"M Sugimoto","year":"1989","unstructured":"Sugimoto M, Nakashima H, Matsumoto M, Uyama E, Ando M, Araki S. Pulmonary involvement in patients with HTLV-I-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid. Am Rev Respir Dis. 1989;139:1329\u201335.","journal-title":"Am Rev Respir Dis"},{"key":"1002_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1046\/j.1365-2249.2003.02240.x","volume":"133","author":"W Matsuyama","year":"2003","unstructured":"Matsuyama W, Kawabata M, Mizoguchi A, Iwami F, Wakimoto J, Osame M. Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity. Clin Exp Immunol. 2003;133:397\u2013403.","journal-title":"Clin Exp Immunol"},{"key":"1002_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.acra.2012.03.020","volume":"19","author":"T Yamashiro","year":"2012","unstructured":"Yamashiro T, Kamiya H, Miyara T, Gibo S, Ogawa K, Akamine T, et al. CT scans of the chest in carriers of human T-cell lymphotropic virus type 1: presence of interstitial pneumonia. Acad Radiol. 2012;19:952\u20137.","journal-title":"Acad Radiol"},{"key":"1002_CR26","doi-asserted-by":"publisher","first-page":"ofu023","DOI":"10.1093\/ofid\/ofu023","volume":"1","author":"L Einsiedel","year":"2014","unstructured":"Einsiedel L, Cassar O, Goeman E, Spelman T, Au V, Hatami S, et al. High HTLV-1 subtype C proviral loads are associated with bronchiectasis in Indigenous Australians: Results of a case-control study. Open forum Infect Dis. 2014;1:ofu023.","journal-title":"Open forum Infect Dis"},{"key":"1002_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002643","volume":"8","author":"L Einsiedel","year":"2014","unstructured":"Einsiedel L, Spelman T, Goeman E, Cassar O, Arundell M, Gessain A. Clinical associations of Human T-lymphotropic Virus type 1 infection in an indigenous Australian population. PLoS Negl Trop Dis. 2014;8, e2643.","journal-title":"PLoS Negl Trop Dis"},{"key":"1002_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cid\/cir766","volume":"54","author":"L Einsiedel","year":"2012","unstructured":"Einsiedel L, Fernandes L, Spelman T, Steinfort D, Gotuzzo E. Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population. Clin Infect Dis. 2012;54:43\u201350.","journal-title":"Clin Infect Dis"},{"key":"1002_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3201\/eid1001.020714","volume":"10","author":"EL Murphy","year":"2004","unstructured":"Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, et al. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis. 2004;10:109\u201316.","journal-title":"Emerg Infect Dis"},{"key":"1002_CR30","first-page":"417","volume-title":"Respiratory Diseases","author":"J Crofton","year":"1981","unstructured":"Crofton J. Bronchiectasis. In: Douglas CJ, editor. Respiratory Diseases. Oxford: Blackwell Scientific; 1981. p. 417\u201330."},{"key":"1002_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","volume":"12","author":"D Weycker","year":"2005","unstructured":"Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12:205\u20139.","journal-title":"Clin Pulm Med"},{"key":"1002_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1440-1754.1994.tb00559.x","volume":"30","author":"MG Flynn","year":"1994","unstructured":"Flynn MG. Hospital admission rates for asthma and pneumonia in Fijian and Indian children. J Paediatr Child Health. 1994;30:19\u201322.","journal-title":"J Paediatr Child Health"},{"key":"1002_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/bmj.289.6437.101","volume":"97","author":"AH Smith","year":"1984","unstructured":"Smith AH, Pearce NE. Determinants of difference in mortality between New Zealand and Maoris and non-Maoris aged 15-64. NZ Med J. 1984;97:101\u20138.","journal-title":"NZ Med J"},{"key":"1002_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1378\/chest.11-1024","volume":"142","author":"PJ McShane","year":"2012","unstructured":"McShane PJ, Naureckas ET, Strek ME. Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture. Chest. 2012;142:159\u201367.","journal-title":"Chest"},{"key":"1002_CR35","first-page":"199","volume":"43","author":"T Arakaki","year":"1992","unstructured":"Arakaki T, Asato R, Ikeshiro T, Sakiyama K, Iwanaga M. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers? Trop Med Parasitol. 1992;43:199\u2013200.","journal-title":"Trop Med Parasitol"},{"key":"1002_CR36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4269\/ajtmh.1999.60.146","volume":"60","author":"E Gotuzzo","year":"1999","unstructured":"Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg. 1999;60:146\u20139.","journal-title":"Am J Trop Med Hyg"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1002-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1002-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1002-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1002-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T20:55:10Z","timestamp":1691787310000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1002-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1002-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]},"article-number":"258"}}